MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7759/cureus.58834

Медицинская библиотека · Cureus · 2024

A Comprehensive Review on the Efficacy of Anti-CD20 Therapies in Pemphigus Treatment.

Khan Arshiya, Singh Adarshlata, Madke Bhushan, Bhatt Drishti M, Jangid Shivani D

СтатьяОбзорПеревод в очереди

Аннотация

Pemphigus, an autoimmune blistering disorder, poses significant therapeutic challenges due to dysregulated B cells and the involvement of CD20. This review assesses the efficacy of anti-CD20 therapies, including rituximab, ofatumumab, ocrelizumab, and obinutuzumab, in pemphigus treatment. Mechanisms of action, clinical studies, and safety profiles were analyzed, revealing diverse impacts on disease severity. B cell depletion emerged as a pivotal factor, disrupting the autoimmune process and reducing pathogenic antibodies. Varied efficacy and safety profiles among agents underscore the need for personalized treatment strategies guided by biomarkers. Challenges such as resistance and long-term safety concerns necessitate continued research and vigilance. In clinical practice, insights from this review inform nuanced, tailored approaches for improved pemphigus management. The dynamic landscape of emerging therapies and personalized medicine emphasizes the need for ongoing research and strategic clinical decision-making. This review is a foundation for future investigations, providing insights for clinicians and researchers in optimizing pemphigus treatment.

Для цитирования: Khan Arshiya, Singh Adarshlata, Madke Bhushan, Bhatt Drishti M, Jangid Shivani D. A Comprehensive Review on the Efficacy of Anti-CD20 Therapies in Pemphigus Treatment.. Cureus. 2024. DOI: 10.7759/cureus.58834.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.